Product information and disease descriptionProduct description
Phase of product development
23 evidence topics · 21 sources
Regulatory status: Submission planned; NDA planned for the fourth quarter of 2026
Launch
No evidence found.
Moderate-to-severe plaque psoriasis
Product information and disease descriptionProduct description
23 evidence topics · 21 sources
No evidence found.